Company / Net Debt per Share
Centessa Pharmaceuticals plc Net Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.33
FY2025
5-year range
-$6.91 / $0.33
FY2021-FY2025
Trend
+115.8%
vs FY2024
Sector context
#44 of 82
Health Care
What the data says
At $0.33, Centessa Pharmaceuticals plc's net debt per share ranks #39 of 82 in the Health Care sector. Increased from $-1.35 to $0.33 over the past 2 years.
Based on SEC 10-K filings.
0.33 in FY2025.
Increased from $-1.35 to $0.33 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#39 of 82 in Health CareTop 46% of 82This company $0.33 Sector average $13.62
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 115.8% year-over-year.
- Ranks #44 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.33 | +115.8% |
| FY2024 | -$2.07 | -53.2% |
| FY2023 | -$1.35 | +61.1% |
| FY2022 | -$3.47 | +49.8% |
| FY2021 | -$6.91 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026